LIFECARE ASA
LIFE
ADDITIONAL REGULATED INFORMATION REQUIRED TO BE DISCLOSED UNDER THE LAWS OF A MEMBER STATE
Minutes from Annual General meeting 2026
The Annual General Meeting (AGM) of Lifecare ASA was held today as a hybrid meeting. All proposals on the agenda were adopted, cf. the notice of the AGM that was published on Oslo Stock Exchange on April 1, 2026.
The minutes are attached and available at https://lifecare.no/investor/governance.
The AGM elected three new directors to the Board: Tore B. Ellingsen, Kathrine Gamborg Andreassen and Renete Kaarvik, all for a period of two years.
The Board of Lifecare ASA thus consists of the following directors:
* Morten Foros Krohnstad (Chair) * Hans Hekland * Tore B. Ellingsen * Kathrine Gamborg Andreassen * Renete Kaarvik
About us Lifecare ASA is a medical sensor company developing technology for sensing and monitoring of various body analytes. Lifecare's focus is to bring the next generation of Continuous Glucose Monitoring systems to market. Lifecare enables osmotic pressure as sensing principle. Lifecare's sensor technology is suitable for identifying and monitoring the occurrence of a wide range of analytes and molecules in the human body and in pets.
Contacts For further information, please contact:
Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40 Petter Nielsen, CFO, petter.nielsen@lifecare.no, +47 92 24 74 64
This information is subject to disclosure under the Norwegian Securities Trading Act, §5-12. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-04-23 10:58 CEST.